BRYCE SOMER: Open Payments
NPI 1508285495 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,663 in 75 payments from 21 companies in 2025. Trend: 2023 $1,463 · 2024 $1,413 · 2025 $1,663
Food & beverage: $1,652Education: $12
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $244 |
| Novo Nordisk Inc | 12 | $209 |
| Novartis Pharmaceuticals Corporation | 7 | $192 |
| AstraZeneca Pharmaceuticals LP | 4 | $157 |
| Lilly USA, LLC | 6 | $139 |
| ABBVIE INC. | 6 | $134 |
| Exact Sciences Corporation | 3 | $89 |
| GlaxoSmithKline, LLC. | 4 | $68 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $50 |
Products named: LEQVIO, NURTEC ODT, BREZTRI, Ozempic, UBRELVY, TRELEGY ELLIPTA, Wegovy, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
